YOU MAY BE ENTITLED TO COMPENSATION AND DAMAGES FOR YOUR INJURIES – WE ARE AVAILABLE TO ASSIST YOU IN YOUR RECOVERY

Johnson & Johnson Recalls Morcellators Used in Hysterectomies, Removal of Uterine Fibroids and other Laparoscopic Surgeries

According to the FDA, the use of morcellators during hysterectomies and other gynecological surgeries can spread cancer cells in the abdominal cavities of women

If you or a family member has had a surgery in which morcellators were used and have been diagnosed with cancer or experience any other adverse effects, you may be entitled to compensation.

• Our firm is vigorously pursuing this matter.
• Our clients have received millions of dollars in medical device lawsuits.
• No Charge or Obligation for Our Experienced Attorney Review

CONTACT US NOW! Do Not Delay As The Applicable Statute Of Limitations May Result In A Complete Bar To Your Claim Regardless Of Its Merit

About Power Morcellators

Morcellation devices, manufactured by Johnson & Johson, are used mostly during hysterectomies and myomectomies, the removal of fibroids or other noncancerous growths in the uterus. It is also used in laparoscopic spleen and renal surgeries. The device is inserted through a small incision to cut tissue into small pieces for easy removal. This instrument makes these surgeries less-invasive and patients experience faster recovery times.

During surgeries to remove fibroids, some of the tissue is later diagnosed as cancerous, even though pre-op testing failed to detect cancer. The spinning action of the morcellators’ blades can spread cancerous tissue, leading to the spreading of advanced-stage cancerous growth. One type of these cancers is metastatic leiomyosarcoma, an aggressive cancer of the uterus. It is estimated that 1 in 350 women may be at risk for developing cancer due to undiagnosed malignant cells being spread after surgeries using morcellators.

The device can also spread healthy tissue throughout the abdomen where it can grow on other organs, causing pain, bowel obstruction and infection.

In April of 2014 the FDA discouraged doctors from using morcellators to remove uterine fibroids due to the increased risk of undiagnosed cancer spreading. Shortly after the warning, Johnson & Johnson pulled its laparoscopic morcellators from the market.

Lawsuits have been filed against Johnson & Johnson by those who were diagnosed with cancer after a morcellation procedure. These plaintiffs claim the company manufactured and marketed a defective product and failed to warn the public of the increased risks and dangers of the use of morcellators.